Literature DB >> 9185723

Analysis of voice changes after thyroplasty using linear predictive coding.

R L Plant1, A D Hillel, P F Waugh.   

Abstract

Objective measurement of vocal quality is difficult in patients with severe voice disorders. Improved success has been reported using a modeling technique known as linear predictive coding. This technique uses an inverse filter to estimate a glottic excitation signal. The pitch amplitude is defined as the height of the first peak of the autocorrelation of the glottic excitation signal. In this study linear predictive coding was used to analyze voice disorders in patients with vocal fold immobility. Voice recordings were made in 16 patients undergoing vocal fold medialization and 10 patients who had no surgical procedure between measurements. The voice quality was rated by three speech pathologists. Five acoustic parameters were calculated from the samples. The best agreement with the listeners' perceptual analysis was achieved using the pitch amplitude. Both pitch amplitude and the perceptual ratings of voice quality improved in patients undergoing vocal fold medialization. Therefore the linear model of speech production and inverse filtering are useful in measuring vocal quality in patients with vocal fold immobility.

Entities:  

Mesh:

Year:  1997        PMID: 9185723     DOI: 10.1097/00005537-199706000-00001

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  Multidimensional assessment of functional outcomes of medialization thyroplasty.

Authors:  Virgilijus Uloza; Ruta Pribuisiene; Viktoras Saferis
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-12-10       Impact factor: 2.503

2.  Pre and post operative voice analysis after medialization thyroplasty in cases of unilateral vocal fold paralysis.

Authors:  Kanishka Chowdhury; Somnath Saha; Vedula Padmini Saha; Sudipta Pal; Indranil Chatterjee
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-03-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.